Urinary exosomal miRNA signatures in type II diabetic nephropathy patients
收藏官方服务：
资源简介：
Urinary exosomal miRNA signatures in type II diabetic nephropathy patients
应用场景：
创建时间：
2016-11-03
相关数据集
The miRNAs in plasma exosomes may serve as markers for non-segmental vitiligo
More and more studies have showed that plasma exosomal miRNAs are biomarkers for disease. The aim of the study were to investigate the miRNA profiling in plasma exosomes of patients with non-segmental
NIAID Data Ecosystem120
File S1 - Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study
Table S1. ORs for new-onset metabolic syndrome components according to baseline DPP4 activity (nmol/ml/min); Table S2. ORs for new-onset metabolic syndrome components according to baseline active GLP-
Figshare2015-12-02 更新70
Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma
A prolonged hyperglycemic condition in diabetes mellitus results in glycation of plasma proteins. N(ε)-Carboxymethyllysine (CML) is a well-known protein advanced glycation end product, and one of its
NIAID Data Ecosystem60
Next generation sequencing showing miRNA profiles of exosomes derived from DHT-treated CAFs and matched ETOH-treated CAFs
Background: Androgen deprivation therapy (ADT) is the backbone of therapy for advanced prostate cancer (PCa). Despite the good initial response, castration resistance and metastatic progression will i
NIAID Data Ecosystem80
Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction
Beta cell dysfunction accompanies and drives the progression of type 2 diabetes mellitus (T2D), but there are few clinical biomarkers available to assess islet cell stress in humans. Secretagogin, a p
NIAID Data Ecosystem60
